Plunkett Research Online: Arch Biopartners Inc

ARCH BIOPARTNERS INC (ARCH) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfol.....


ARCH BIOPARTNERS INC

Ticker: ARCH
Exchange: TSXV
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 647 428-7031
Fax: 647 428-7032
Address:
Toronto, ON M5V 1M1 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Richard MuruveCEO/Co-Founder/Director/President
Andrew BishopCFO/Director
See More
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfol.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture